FE 203799

· GlyPharma Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FE 203799, covering 2024-10-24 to 2024-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas [Phase 1, Phase 2]